Enhanced collaboration between US NIH and WHO on biomedical research

Information

  • Research Project
  • 9281629
  • ApplicationId
    9281629
  • Core Project Number
    U01AI108543
  • Full Project Number
    5U01AI108543-05
  • Serial Number
    108543
  • FOA Number
    RFA-AI-12-055
  • Sub Project Id
  • Project Start Date
    6/15/2013 - 11 years ago
  • Project End Date
    5/31/2018 - 6 years ago
  • Program Officer Name
    MEEGAN, JAMES M.
  • Budget Start Date
    6/1/2017 - 7 years ago
  • Budget End Date
    5/31/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    05
  • Suffix
  • Award Notice Date
    7/24/2017 - 7 years ago

Enhanced collaboration between US NIH and WHO on biomedical research

DESCRIPTION (provided by applicant): The World Health Organization (WHO) is the lead technical agency in health matters, acting as the directing and coordinating authority on international health work. Today, WHO counts 194 Member States. WHO fulfills its objectives through six core functions, which include the shaping of the research agenda and stimulating the generation, translation and dissemination of valuable knowledge. WHO's roles and responsibilities in health research have recently been endorsed by the World Health Assembly. WHO utilizes its decentralized structure to implement its research efforts at global, regional and country level. To achieve its objectives related to research, WHO maintains effective collaboration with governmental and other research organizations throughout the world, as evidenced by the network of WHO Collaborating Centers. Covering programs on communicable and non-communicable diseases, endemic, epidemic as well as emerging health threats, WHO addresses a research portfolio with broad complementarity to the goals of NIH and many of its 27 centers and specialized institutes. Based on a track-record of fruitful collaboration between WHO and NIH, the objective of this application is to support a framework of enhanced collaboration in the area of biomedical research. Working towards shared goals of WHO and NIH, it is intended is to build on the respective strengths of both Organizations. In the field of biomedical research, NIH's more basic research emphasis combines with WHO's application oriented research efforts, and its support to research-related training efforts, the fostering of research-related resources, the dissemination of scientific knowledge and the assessment of health-related research and good practices. To implement the proposed collaborative effort, WHO relies on its very broad program experience, its experience as research sponsor, its ability to convene world-leading experts and manage transparent an independent consultation processes, its decentralized infrastructure comprising six regional offices and 146 country offices, and a continuous programmatic and financial commitment. Within the financial limits of this RFA, WHO proposes to conduct annual expert consultations on the assessment and application of novel and innovative biomedical research findings for the development of priority public health interventions in low and middle income countries. There is very significant room for expansion of collaborative activities in support of both institutions shared goals and objectives.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    569454
  • Indirect Cost Amount
    74029
  • Total Cost
    318624
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NCI:243440\NIAID:75184\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    WORLD HEALTH ORGANIZATION
  • Organization Department
  • Organization DUNS
    480997543
  • Organization City
    GENEVA
  • Organization State
  • Organization Country
    SWITZERLAND
  • Organization Zip Code
    1211
  • Organization District
    SWITZERLAND